Page 2 - FLIPBOOK

Speakers & Disclosures

Trial funding from: Cancer Research UK, Medical
Nicholas James Research Council, Astellas, Janssen, Novartis, Pfizer,
Professor of Prostate and Bladder Cancer Sanofi-Aventis
The Institute of Cancer Research Speaking fees and Advisory Boards: AAA, a Novartis
Royal Marsden Hospital, company, Astellas, Astra Zeneca, Bayer, Clovis,
London, UK Ferring, Janssen, Merck, Novartis, Pfizer, Sanofi-
Aventis

Advisory Board: Abbott, Amgen, Astellas, Bayer,
Ricardo Rendon Ferring, Janssen
Urological Oncologist, Speakers’ Bureau: Amgen, Astellas, Bayer, Ferring,
Professor, Department of Urology, Janssen
Dalhousie University Grant/Honorarium: Astellas, Amgen, Bayer, Janssen
QEII Health Sciences Centre Clinical Trial: AbbVie, Amgen, Astellas, Bayer,
Bavarian Nordic, Ferring, Janssen

Vincent Fradet Speakers’ Bureau: Abbvie, Amgen, Bayer, Ferring,

Urologue Oncologue CHU de Québec Janssen, Sanofi
Université Laval Grant/Honorarium: Amgen, AstraZeneca, Astellas,
Professeur agrégé, Département de chirurgie Janssen, Sanofi
Associate Professor Clinical Trial: AstraZeneca, Astellas, Bayer, Janssen,
Sanofi, Roche